Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.
about
The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directionsRecent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic reviewThe Effects of Bowel Preparation on Microbiota-Related Metrics Differ in Health and in Inflammatory Bowel Disease and for the Mucosal and Luminal Microbiota CompartmentsClinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease.Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies.Human gut microbiota changes reveal the progression of glucose intolerance.Understanding how commensal obligate anaerobic bacteria regulate immune functions in the large intestine.Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease.Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.Characterization of gut microbiota profiles by disease activity in patients with Crohn's disease using data mining analysis of terminal restriction fragment length polymorphisms.Bacterial diversity and Clostridia abundance decrease with increasing severity of necrotizing enterocolitis.Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, PlaceA breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease.Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycinOsteopontin Deficiency Accelerates Spontaneous Colitis in Mice with Disrupted Gut Microbiota and Macrophage Phagocytic Activity.Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel DiseasesTNFR2 Deficiency Acts in Concert with Gut Microbiota To Precipitate Spontaneous Sex-Biased Central Nervous System Demyelinating Autoimmune Disease.Gut Microbiome Diversity among Cheyenne and Arapaho Individuals from Western OklahomaAdministration of Non-Absorbable Antibiotics to Pregnant Mice to Perturb the Maternal Gut Microbiota Is Associated with Alterations in Offspring Behavior.Allergic Patients with Long-Term Asthma Display Low Levels of Bifidobacterium adolescentis.Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosisReduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population.Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functionsLipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages.Genomic Microdiversity of Bifidobacterium pseudocatenulatum Underlying Differential Strain-Level Responses to Dietary Carbohydrate Intervention.Association between Faecalibacterium prausnitzii Reduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the Literature.Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.Diet Versus Phylogeny: a Comparison of Gut Microbiota in Captive Colobine Monkey Species.The effect of NOD2 on the microbiota in Crohn's disease.Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases.The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn's Disease: A Review.Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study.Understanding the canine intestinal microbiota and its modification by pro-, pre- and synbiotics - what is the evidence?Intestinal dysbacteriosis contributes to decreased intestinal mucosal barrier function and increased bacterial translocation.Casein hydrolysate diet controls intestinal T cell activation, free radical production and microbial colonisation in NOD mice.Gut Fermentation of Dietary Fibres: Physico-Chemistry of Plant Cell Walls and Implications for Health.Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis.
P2860
Q26745700-BBEBD510-7F0E-4E9D-9DCE-898368D83A91Q27000726-EA0D1537-424F-4635-9A08-89D9E66A7828Q27325522-94F79B6A-584A-48B1-967A-15E2892B7B22Q30490594-CAB6A8FF-48EB-4B06-A0A3-B34812FF4BAAQ34786166-EA891587-9155-464C-B77D-A2630A6A74AFQ34980773-26AC4157-1098-4699-BBFD-BEE3EF374826Q35003724-EFDA28BF-8316-46FA-A859-308973877E3AQ35044905-D91CBE37-9818-47BE-8301-4840C5DBCF35Q35085234-5F4712EF-3593-4B8A-BADF-7F7D8E426C7FQ35107269-4A941F31-0237-4D38-A55E-A41597D1D914Q35153305-E35CDCB5-4FD4-480B-9E43-E80A6CDC414EQ35216513-9772B43D-2E73-4EB1-9FC1-B6357C96CFB9Q35613451-B35409E6-8BF4-4B2E-A20E-BFBCBA7D7E58Q35621970-4FE4CEAA-EF9E-46FA-B3ED-535828797E3BQ35692976-A6C07267-C39E-41CD-B1F9-2FE920A6DD9CQ35746298-522F8944-FF11-4930-A27F-D7BA39F93617Q35755739-D2FBC6D7-D37D-49D2-8CD7-42C25E7E9D20Q35811308-6851CD73-F2CA-4D77-8F1A-248D46EA7E56Q35869822-58B8E43E-CD39-4A71-9DE2-86D2F4FF3956Q35899043-79D32EBE-1BAC-478E-8DDA-FF0590EC7A18Q35913465-64BAE295-2096-47A9-8666-893564F59C02Q35955651-AFF64DE3-B9C7-4E35-94A0-56F4DA36CF2AQ36060516-A54D600D-FF17-43A1-954B-9A08B9654294Q37067036-25A05608-52FB-4813-9B1A-3BB7AA3F434EQ37157802-0AF8CC4B-459A-4810-B50C-1A49CC61FDF1Q37335648-41AEFAB1-B48B-4474-AD4D-31B38ACCFE3CQ37644494-96917B08-E327-489B-8444-4BDA4CB9DA9BQ37700559-677A9346-F5A6-432B-8EF2-8CA992CE3E66Q38663475-494F8A1C-5102-4C23-A309-67AEC77AD04FQ38666271-400128D3-FB5F-461A-BFC6-23082EA490D5Q38795438-ABD1D893-9B8A-4F32-B452-8E5A5E055F96Q39065664-CBAE8478-2774-4867-9864-0B0065ECE8F2Q39077398-D9C4F814-8C95-48E7-AEF0-99879B4D7EAFQ39281074-10FED9E8-D6B0-48E5-9393-65D822EE171EQ40867661-53D54AFB-8FB5-4CF3-A84D-5C4366719818Q42657761-AC3FC050-84F1-4F55-B33C-09745F6AE98BQ43607004-22AFEA5C-5CAD-4B68-974E-61F7C8DD6B79Q43949037-3413490D-1920-481A-A0D3-215B22DBA3EDQ44764581-E83E5F4E-CC8C-469C-8AA7-F3A25A220656Q44822234-A5182FA5-11D0-49B1-8BA0-73FBD740A93B
P2860
Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Decreased abundance of Faecali ...... microbiota of Crohn's disease.
@en
Decreased abundance of Faecali ...... microbiota of Crohn's disease.
@nl
type
label
Decreased abundance of Faecali ...... microbiota of Crohn's disease.
@en
Decreased abundance of Faecali ...... microbiota of Crohn's disease.
@nl
prefLabel
Decreased abundance of Faecali ...... microbiota of Crohn's disease.
@en
Decreased abundance of Faecali ...... microbiota of Crohn's disease.
@nl
P2093
P2860
P356
P1476
Decreased abundance of Faecali ...... microbiota of Crohn's disease
@en
P2093
Akira Andoh
Eiji Kasumi
Kenichiro Takahashi
Shigeki Bamba
Takehide Fujimoto
Yoshihide Fujiyama
P2860
P304
P356
10.1111/JGH.12073
P577
2013-04-01T00:00:00Z